Accurate hydrocortisone dosing can provide safe and effective treatment in children with adrenal insufficiency
Dosing accuracy in children with adrenal insufficiency is essential. If a child gets too much (overdosing) or too little (underdosing) hydrocortisone, they may experience poor health outcomes that can last for a long time, even into their adult years.2-5
Overdosing can lead to long-term health problems
If your child gets more hydrocortisone than prescribed, they are at risk for long-term health problems that could last into adulthood.6
Underdosing can lead to short-term health problems
If your child gets less hydrocortisone than prescribed, they could be in immediate danger.6
No representation is made for ALKINDI SPRINKLE in relation to these conditions.
The only hydrocortisone treatment designed specifically for children with adrenal insufficiency
No pill splitting
No pill crushing
ALKINDI SPRINKLE: Made with kids in mind
Accurately treat your child with the dose your doctor prescribed by following the Instructions for Use.
ALKINDI SPRINKLE is a granular version of hydrocortisone developed and approved for the treatment of adrenal insufficiency in newborns and children. The hydrocortisone oral granules are small enough to sprinkle onto soft food, like yogurt or applesauce, or directly into your child’s mouth. The capsules are designed to be opened and the medicine given on a full or empty stomach with a sip of fluids to ensure all granules are swallowed.
Always give ALKINDI SPRINKLE exactly as prescribed by your doctor.
ALKINDI SPRINKLE helps provide kids with accurate hydrocortisone dosing
Learn more about accurate hydrocortisone treatment for children with adrenal insufficiency.
Get a free coloring book when you join the ALKINDI SPRINKLE community
Join the ALKINDI SPRINKLE community to stay informed and up to date. You’ll receive the latest news, information, and so much more.
References: 1. ALKINDI SPRINKLE. Package insert. Eton Pharmaceuticals, Inc; 2022. 2. Han TS, Conway GS, Willis DS, et al. Relationship between final height and health outcomes in adults with congenital adrenal hyperplasia: United Kingdom congenital adrenal hyperplasia adult study executive (CaHASE). J Clin Endocrinol Metab. 2014;99:E1547‐E1555. 3. Oprea A, Bonnet NCG, Pollé O, Lysy PA. Novel insights into glucocorticoid replacement therapy for pediatric and adult adrenal insufficiency. Ther Adv Endocrinol Metab. 2019;10:2042018818821294. doi:10.1177/2042018818821294 4. Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(2):364-389. doi:10.1210/ jc.2015-1710 5. Debono M, Newell Price J, Ross RJ. Novel strategies for hydrocortisone replacement. Best Pract Res Clin Endocrinol Metab. 2009;23(2):221-232. doi:10.1016/j.beem.2008.09.010 6. Neumann U, Whitaker MJ, Wiegand S, et al. Absorption and tolerability of taste-masked hydrocortisone granules in neonates, infants and children under 6 years of age with adrenal insufficiency. Clin Endocrinol (Oxf). 2018;88(1):21-29. doi:10.1111/cen.13447